Harold Davidson & Associates
ABBV icon

Harold Davidson & Associates’s AbbVie ABBV Stock Holding History

Harold Davidson & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.69M Buy
14,123
+61
+0.4% +$15.6K 1.5% 17
2026
Q2 		$3.54M Buy
14,062
+656
+5% +$141K 1.53% 16
2026
Q1 		$2.92M Buy
13,406
+205
+2% +$45.5K 1.42% 19
2025
Q4 		$3.02M Buy
13,201
+2,338
+22% +$533K 1.33% 19
2025
Q3 		$2.52M Buy
10,863
+1,299
+14% +$265K 1.14% 21
2025
Q2 		$1.78M Sell
9,564
-172
-2% -$32K 1.15% 20
2025
Q1 		$2.04M Sell
9,736
-209
-2% -$40.6K 1.11% 22
2024
Q4 		$1.77M Buy
+9,945
New +$1.83M 0.85% 31

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Harold Davidson & Associates's ABBV Position: Q3 2026 in Review

Harold Davidson & Associates increased its AbbVie (ABBV) stake by 0.43% in Q3 2026, buying an estimated $15.6K and bringing the position to 14,123 shares worth $3.69M. The position accounts for 1.5% of the portfolio, ranked #17.

Harold Davidson & Associates first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Harold Davidson & Associates held 14,123 shares of AbbVie worth $3.69M as of Q3 2026.
  • Harold Davidson & Associates bought 61 AbbVie shares in Q3 2026, an estimated $15.6K.
  • AbbVie made up 1.5% of Harold Davidson & Associates's portfolio in Q3 2026, its #17 holding.
  • Harold Davidson & Associates first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Harold Davidson & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.